Article

Wills Eye Hospital promotes Dr. Kammi Gunton to chief of pediatric ophthalmology service

Expansion of program aims to provide more children with improved eye care; enhance the teaching of Wills residents and fellows

Wills Eye Hospital announces the promotion of Kammi B. Gunton, MD to chief of the pediatric ophthalmology service.

Gunton is a board-certified ophthalmologist who specializes in pediatric and adolescent ophthalmology and strabismus in adults. She previously served as the interim director of pediatric ophthalmology at Wills Eye and began her new role on March 11, 2022.

Wills Eye Hospital promotes Dr. Kammi Gunton to chief of pediatric ophthalmology service

Gunton

The service manages the care of eye diseases in children including such common challenges as misaligned eyes or poor visual development as well as complex cases with systemic associations. Pediatric ophthalmologists on the staff also engage in educational and research activities in addition to the clinical and surgical care of patients.

“We want to expand the reach of the Wills pediatric ophthalmology service so that we can provide pediatric eye care in community practices throughout the greater Philadelphia area,” Gunton said. “Expansion will not only provide more young Philadelphians with improved eye care but will enhance the teaching of Wills residents and fellows.”

Among many recent successes, Gunton has driven growth in clinical and research efforts, recruited new team members, and received grants to support the work of the service, said Julia A. Haller, MD, ophthalmologist-in-chief of Wills Eye Hospital.

Gunton has published numerous articles including a recent study on the impact of virtual schooling on children’s eyesight which received national attention.

Gunton is a graduate of Stanford University and received her medical degree from the University of California, San Francisco. She pursued her residency and fellowship training at Wills Eye and has been a pediatric ophthalmologist at the hospital since 2003.

Related Videos
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
Arun Gulani, MD: How the Gni instrument enhances precision and control in cataract surgery
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
© 2024 MJH Life Sciences

All rights reserved.